Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGM vs Conventional Monitoring in Renal Transplant
NCT04742023Phase 1Completed
- Sponsor
- Northwell Health
- Start
- Apr 2020
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial (2 arms), sponsored by Northwell Health. Primary endpoint: Average Daily Glucose. Started Apr 2020; status: completed.
Beyond the preview
Go deeper on NCT04742023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742023.